Clinical TrialsSearch results
Number of results: 718
Other
- Immunotherapy Using HLA-A24-restricted Survivin-derived Peptide for Patients with Colorectal Cancer and Breast Cancer
- Advanced or recurrent colorectal cancer and breast cancer
- Department of Surgery, Sapporo Medical University School of Medicine
- 2007-11-23
Other
- Immunotherapy Using HLA-A24-restricted Survivin-derived Peptide Mixed with IFA, IFA and IFN-alpha, IFA and IL-2, or IFA and GM-CSF for Patients with Digestive Cancer and Endocrine Organic Cancer (Phase I clinical study)
- Advanced or recurrent digestive cancer and Endocrine Organic Cancer
- Department of Surgery, Sapporo Medical University School of Medicine
- 2007-11-23
Other
- A study to observe correlation between resection and reconstruction procedures employed for gastric neoplasms and development of postgastrectomy syndrome
- Gastric cancer patients who underwent various types of gastrectomy (GIST patients who underwent gastric wedge resection are also included)
- Department of Surgery, The Jikei University School of Medicine
- 2009-06-25
Other
- The efficacy and feasibility of the repeated intraperitoneal Paclitaxel +systemic TS-1 and Paclitaxel for far advanced or recurrent gastric cancer: Phase I/II trial.
- Far advanced or recurrent gastric cancer
- Department of Surgical Oncology The University of Tokyo
- 2008-08-30
Recruiting
- Phase II study of prophylactic oral administration of diltiazem for atrial fibrillation after lung resection
- atrial fibrillation after lung resection
- Department of Surgical Oncology, Hokkaido University Graduate School of Medicine
- 2009-02-06
Other
- The phase I,II clinical study of cancer vaccine for intractable malignant tumor expressing MAGE-A4-antigen
- Intractable malignant tumors expressing MAGE-A4 antigen
- Department of Surgical Oncology, Hokkaido University Graduate School of Medicine
- 2009-05-22
Other
- Efficacy and Safety of Zoledronic acid on urological cancer patients with bone metastasis: a phase II clinical study.
- Urological Cancer with bone metastasis (Hormone resistant prostate cancer, Kidney cancer, urothelial cancer, kidney pelvis and ureteral cancer)
- Department of Urology, Graduate School of Medical Sciences, Kyushu University
- 2009-08-10
Other
- Immunotherapy Using HLA-A24-restricted Survivin-derived Peptide for Patients with Urothelial Cancer (Phase I clinical study)
- Advanced or recurrent urothelial cancer
- Department of Urology, Sapporo Medical University School of Medicine
- 2008-11-11
Recruiting
- Vaccination trial with the PBF-derived peptide in HLA-A2+ patients with osteosarcoma
- osteosarcoma
- Dept Orthopaedic Surgery, Sapporo Medical University
- 2009-01-14
Recruiting
- Vaccination trial with the PBF-derived peptide in HLA-A24+ patients with osteosarcoma
- Osteosarcoma
- Dept Orthopaedic Surgery, Sapporo Medical University
- 2009-01-14